Search research articles
Contact Us
Filters
Showing results (161-170 of 192) with videos related to
Page
of 20
Sort By:
The Journal of Antimicrobial Chemotherapy
|
April 19, 2018
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial
Massimiliano Fabbiani, Roberta Gagliardini, Nicoletta Ciccarelli, et al.
AIDS (London, England)
|
March 17, 2023
Incident diabetes in course of antiretroviral therapy
Lucia Taramasso, Nicola Squillace, Elena Ricci, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
Laura Waters, Lambert Assoumou, Ana González-Cordón, et al.
Pharmacological Research
|
May 25, 2020
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study
Andrea Giacomelli, Anna Lisa Ridolfo, Laura Milazzo, et al.
Elife
|
March 2, 2021
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study
Chiara Fallerini, Sergio Daga, Stefania Mantovani, et al.
Sexually Transmitted Infections
|
April 21, 2022
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy
Giorgio Bozzi, Lavinia Fabeni, Isabella Abbate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial
Abiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Antimicrobial Resistance and Infection Control
|
August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres
Agnese Comelli, Camilla Genovese, Andrea Lombardi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 27, 2020
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study
Andrea Gori, Andrea Antinori, Alessandra Vergori, et al.
Pharmacological Research
|
May 15, 2020
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
Spinello Antinori, Maria Vittoria Cossu, Anna Lisa Ridolfo, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 192) with videos related to
Sort By:
Page
of 20
The Journal of Antimicrobial Chemotherapy
|
April 19, 2018
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial
Massimiliano Fabbiani, Roberta Gagliardini, Nicoletta Ciccarelli, et al.
AIDS (London, England)
|
March 17, 2023
Incident diabetes in course of antiretroviral therapy
Lucia Taramasso, Nicola Squillace, Elena Ricci, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
Laura Waters, Lambert Assoumou, Ana González-Cordón, et al.
Pharmacological Research
|
May 25, 2020
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study
Andrea Giacomelli, Anna Lisa Ridolfo, Laura Milazzo, et al.
Elife
|
March 2, 2021
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study
Chiara Fallerini, Sergio Daga, Stefania Mantovani, et al.
Sexually Transmitted Infections
|
April 21, 2022
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy
Giorgio Bozzi, Lavinia Fabeni, Isabella Abbate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial
Abiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Antimicrobial Resistance and Infection Control
|
August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres
Agnese Comelli, Camilla Genovese, Andrea Lombardi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 27, 2020
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study
Andrea Gori, Andrea Antinori, Alessandra Vergori, et al.
Pharmacological Research
|
May 15, 2020
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
Spinello Antinori, Maria Vittoria Cossu, Anna Lisa Ridolfo, et al.
Page
of 20